Stevanato Group S.p.A (STVN) Shares Outstanding (Diluted Average) (2020 - 2026)
Stevanato Group S.p.A (STVN) reported Shares Outstanding (Diluted Average) of $319.6 million for Q1 2026, up 11.34% year-over-year from $287.1 million in Q1 2025, and up 0.58% quarter-over-quarter from $317.8 million in Q4 2025.
Stevanato Group S.p.A (STVN) Shares Outstanding (Diluted Average) (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has 7 years of Shares Outstanding (Diluted Average) data on file, last reported at $319.6 million in Q1 2026.
- Shares Outstanding (Diluted Average) for Q1 2026 came in at $319.6 million, up 11.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $319.6 million (up 11.34% YoY), and the FY2025 annual result was $317.8 million, up 8.97% from the prior year.
- Shares Outstanding (Diluted Average) improved to $319.6 million in Q1 2026 per STVN's latest filing, from $317.8 million in the prior quarter.
- Over five years, Shares Outstanding (Diluted Average) peaked at $319.6 million in Q1 2026 and troughed at $266.9 million in Q3 2022.
- A 5-year average of $293.6 million and a median of $289.0 million in 2023 frame the typical range for Shares Outstanding (Diluted Average).
- The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Diluted Average) slipped 14.44% in 2022, then gained 11.34% in 2026.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $270.1 million in 2022, then climbed by 5.78% to $285.7 million in 2023, then advanced by 2.09% to $291.6 million in 2024, then grew by 8.97% to $317.8 million in 2025, then increased by 0.58% to $319.6 million in 2026.
- Business Quant data shows STVN's Shares Outstanding (Diluted Average) at $319.6 million in Q1 2026, $317.8 million in Q4 2025, and $319.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 359.80 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 824.84 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 145.72 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 72.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 175.50 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 195.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 71.61 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 515.00 Mn |
| 10 | Stevanato Group S.p.A | 433.37 Mn | 290.42 Mn | 88.01 Mn | 319.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 319.61 Mn |
| Dec 31, 2025 | 317.78 Mn |
| Sep 30, 2025 | 319.15 Mn |
| Jun 30, 2025 | 308.91 Mn |
| Mar 31, 2025 | 287.06 Mn |
| Dec 31, 2024 | 291.62 Mn |
| Sep 30, 2024 | 299.70 Mn |
| Jun 30, 2024 | 293.77 Mn |
| Mar 31, 2024 | 288.97 Mn |
| Dec 31, 2023 | 285.66 Mn |
| Sep 30, 2023 | 288.48 Mn |
| Jun 30, 2023 | 289.00 Mn |
| Mar 31, 2023 | 284.86 Mn |
| Dec 31, 2022 | 270.06 Mn |
| Sep 30, 2022 | 266.89 Mn |
| Jun 30, 2022 | 282.45 Mn |
| Mar 31, 2022 | 297.08 Mn |
| Dec 31, 2021 | 302.81 Mn |
| Sep 30, 2021 | 311.92 Mn |
| Jun 30, 2021 | 290.23 Mn |